Stay updated on Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page
- Check5 days agoChange DetectedA new revision entry v3.6.2 was added to the study record history. The previous revision v3.6.0 was removed from the visible history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdds a recruitment status 'No longer looking for participants' and records the new revision 'Revision: v3.6.0', while removing the older 'Revision: v3.5.5' entry from the history.SummaryDifference0.4%

- Check26 days agoChange DetectedA new revision entry, v3.5.5, was added to the record history, replacing the previous v3.5.4.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry labeled v3.5.4 was added to the Record History, replacing the previous revision v3.5.3. This indicates an update to the study record and its version history.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page footer’s revision/version indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision history updated from v3.5.0 to v3.5.2. This appears to be a backend version update with no visible content changes.SummaryDifference0.1%

Stay in the know with updates to Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.